Skip to content

Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)

Efficacy of Functional Electrical Stimulation in Dysphagia of Nasopharyngeal Cancer Post Radiotherapy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00815087
Enrollment
20
Registered
2008-12-29
Start date
2008-07-31
Completion date
2013-10-31
Last updated
2014-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia

Keywords

Nasopharyngeal carcinoma, functional electrical stimulation

Brief summary

The purpose of this study is to determine whether functional electrical stimulation is effective in the treatment of dysphagia due to nasopharyngeal cancer post radiotherapy

Detailed description

Nasopharyngeal carcinoma (NPC) patients usually underwent radiotherapy (RT) or chemoradiotherapy(CRT). There were some complications caused by RT, like dysphagia. In recent studies, functional electrical stimulation (FES) was be used in neurologically dysphagia patients, and there were some positive effects with these studies. Hence, we decided applied FES to these NPC patients with dysphagia.

Interventions

DEVICEFunctional electrical stimulation

15 sessions of VitalStim® therapy, 60 minutes per session

BEHAVIORALExercise home program

Daily exercise training

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary nasopharyngeal carcinoma * Post radiation therapy * Mild to severe dysphagia * Never underwent swallowing therapy

Exclusion criteria

* Recurrent cancer * Neurological or degenerate disease * Total or partial laryngectomy * Epilepsy * With cardiac pacemaker

Design outcomes

Primary

MeasureTime frameDescription
The Change From Baseline and Cut Point VFSS in Velocity of Displacement of Hyoid Bone at 1 to 3 MonthsAveraged 2 monthsA parameter of the VFSS assessment was velocity of displacement of hyoid bone on 5mL thin barium sulfate bolus, which was defined as the displacement divided by the duration. The outcome measure time frame was based on VFSS assessment with the range between one to three months due to subjects received 1 to 3 times per week. We will provide the mean time frame, which is 2 months.

Secondary

MeasureTime frame
Questionnaire of Life Quality1 to 3 months

Participant flow

Recruitment details

Twenty subjects were referral from department of oncology & physical Medicine and Rehabilitation, National Taiwan University Hospital, Taipei, Taiwan. The study was approved by the Ethics Committee of the National Taiwan University Hospital. All participants gave their informed consent.

Pre-assignment details

They were assigned into the FES group and home rehabilitation program (HRP) group by the method of sex stratified randomization, and were matched by Dysphagia Outcome and Severity Scale (DOSS) score within 1 unit in order to compare two groups under the same sex proportion and similar DOSS score pairs.

Participants by arm

ArmCount
Functional Electrical Stimulation (FES)
Functional electrical stimulation: Experimental Functional electrical stimulation : 15 sessions of VitalStim® therapy, 60 minutes per session
10
Home Rehabilitation Program (HRP)
Exercise home program Exercise home program : Daily exercise training
10
Total20

Baseline characteristics

CharacteristicHome Rehabilitation Program (HRP)Functional Electrical Stimulation (FES)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants10 Participants20 Participants
Age, Continuous56.1 years
STANDARD_DEVIATION 11.8
52.3 years
STANDARD_DEVIATION 7.4
54.2 years
STANDARD_DEVIATION 10.3
Region of Enrollment
Taiwan
10 participants10 participants20 participants
Sex: Female, Male
Female
4 Participants4 Participants8 Participants
Sex: Female, Male
Male
6 Participants6 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

The Change From Baseline and Cut Point VFSS in Velocity of Displacement of Hyoid Bone at 1 to 3 Months

A parameter of the VFSS assessment was velocity of displacement of hyoid bone on 5mL thin barium sulfate bolus, which was defined as the displacement divided by the duration. The outcome measure time frame was based on VFSS assessment with the range between one to three months due to subjects received 1 to 3 times per week. We will provide the mean time frame, which is 2 months.

Time frame: Averaged 2 months

ArmMeasureValue (MEAN)Dispersion
Functional Electrical Stimulation (FES)The Change From Baseline and Cut Point VFSS in Velocity of Displacement of Hyoid Bone at 1 to 3 Months0.8 cm/sStandard Deviation 0.5
Home Rehabilitation Program (HRP)The Change From Baseline and Cut Point VFSS in Velocity of Displacement of Hyoid Bone at 1 to 3 Months-0.4 cm/sStandard Deviation 0.8
Secondary

Questionnaire of Life Quality

Time frame: 1 to 3 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026